Crossmark

The rationale for the aggressive progression of MASLD in patients with type 2 diabetes

Crossref DOI link: https://doi.org/10.1016/j.aohep.2025.101778

Published Print: 2025-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Fernández-Garibay, Valeria Michelle

Chavez-Tapia, Norberto C.
License Information

Text and Data Mining valid from 2025-01-01

Text and Data Mining valid from 2025-01-01

Version of Record valid from 2025-01-14
More Information

This article is maintained by: Elsevier

Article Title: The rationale for the aggressive progression of MASLD in patients with type 2 diabetes

Journal Title: Annals of Hepatology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aohep.2025.101778

Content Type: simple-article

Copyright: © 2025 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U.